Gennova has been working on self-amplifying mRNA vaccine. mRNA vaccines use body’s machinery to make antigenic protein rather ...

Trinity College Dublin researchers have found that the BNT162b2 COVID-19 vaccine may offer protection beyond its intended ...

Intranasal influenza virus-vectored vaccine offers protection against clade 2.3.4.4b H5N1 infection in small animal models. Nature Communications , 2025; 16 (1) DOI: 10.1038/s41467-025-58504-z ...

BNT162b2 mRNA vaccination attenuates innate immune function in humans - ...

Dengue’s rise in 2024, influenced by climate change and shifting serotypes, underscores the need for effective vaccines to ...

Empathetic and persistent communication is key when it comes to talking to parents who are reluctant to vaccinate their child ...

Filoviruses are among the globe's most lethal—indeed, so dangerous they can be handled only in high-security laboratories. Yet, more than five decades after the discovery of the Marburg virus and ...

The global market for viral vector and plasmid DNA manufacturing is undergoing a rapid transformation, driven by the explosive growth of gene therapies, cell-based treatments, and DNA vaccines. With ...

India may have a dengue vaccine as early as next year. Developed by Japanese major Takeda, the vaccine named ‘Qdenga’ will be ...

Researchers have created an H5N1 avian influenza, or bird flu, vaccine that can be administered as a nasal spray. The influenza virus vector-based nasal spray vaccine platform was first developed ...

The State Key Laboratory for Emerging Infectious Diseases at the University of Hong Kong (HKU) and the InnoHK Centre for Virology, Vaccinology and Therapeutics (CVVT) have pioneered an influenza virus ...